IMA-930

N/A

Report date: 2025/01/26 17:43:24

Base Information

Drug NameIMA-930

Drug Alias NameTUMAP vaccine (immatics)tumor-associated peptide vaccine (immatics)IMA-930

ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineBiologics > Protein drugs > Recombinant polypeptideBiologics > Antigen > Tumor antigen +[4]

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermanySwitzerland

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesImmatics NV

China Registration ClassN/A

Develop Information

Active CompaniesRoche Holding Ltd

Inactive CompaniesImmatics NV

Active IndicationsCarcinoma, Non-Small-Cell Lung

Inactive IndicationsN/A

Other Information

ATC CodeN/A